Obesidad, adipogénesis y resistencia a la insulina

Endocrinología y Nutrición - Tập 58 Số 7 - Trang 360-369 - 2011
Manuel Ros1, Gema Medina‐Gómez1
1Departamento de Bioquímica, Fisiología y Genética Molecular, Universidad Rey Juan Carlos, Facultad de Ciencias de la Salud, Alcorcón, Madrid, España

Tóm tắt

Từ khóa


Tài liệu tham khảo

Mokdad, 2001, The continuing epidemics of obesity and diabetes in the United States, Jama, 286, 1195, 10.1001/jama.286.10.1195

Facchini, 2001, Insulin resistance as a predictor of age-related diseases, J Clin Endocrinol Metab, 86, 3574, 10.1210/jc.86.8.3574

Reaven, 2005, The insulin resistance syndrome: definition and dietary approaches to treatment, Annu Rev Nutr, 25, 391, 10.1146/annurev.nutr.24.012003.132155

Grant, 2006, Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes, Nat Genet, 38, 320, 10.1038/ng1732

Voight, 2010, Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis, Nat Genet, 42, 579, 10.1038/ng.609

Speliotes, 2010, Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index, Nat Genet, 42, 937, 10.1038/ng.686

Heid, 2010, Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution, Nat Genet, 42, 949, 10.1038/ng.685

Meyre, 2009, Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations, Nat Genet, 41, 157, 10.1038/ng.301

Scherag, 2010, Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups, PLoS Genet, 6, e1000916, 10.1371/journal.pgen.1000916

Thorleifsson, 2009, Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity, Nat Genet, 41, 18, 10.1038/ng.274

Willer, 2009, Six new loci associated with body mass index highlight a neuronal influence on body weight regulation, Nat Genet, 41, 25, 10.1038/ng.287

Schenk, 2008, Insulin sensitivity: modulation by nutrients and inflammation, J Clin Invest, 118, 2992, 10.1172/JCI34260

Ogawa, 1998, Role of binding proteins to IRS-1 in insulin signalling, Mol Cell Biochem, 182, 13, 10.1023/A:1006862807598

Accili, 1996, Early neonatal death in mice homozygous for a null allele of the insulin receptor gene, Nat Genet, 12, 106, 10.1038/ng0196-106

Joshi, 1996, Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality, Embo J, 15, 1542, 10.1002/j.1460-2075.1996.tb00498.x

Shirakami, 2002, Heterozygous knockout of the IRS-1 gene in mice enhances obesity-linked insulin resistance: a possible model for the development of type 2 diabetes, J Endocrinol, 174, 309, 10.1677/joe.0.1740309

Kriauciunas, 2000, Cellular compartmentalization in insulin action: altered signaling by a lipid-modified IRS-1, Mol Cell Biol, 20, 6849, 10.1128/MCB.20.18.6849-6859.2000

Saltiel, 2001, Insulin signalling and the regulation of glucose and lipid metabolism, Nature, 414, 799, 10.1038/414799a

Araki, 1994, Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene, Nature, 372, 186, 10.1038/372186a0

Tamemoto, 1994, Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1, Nature, 372, 182, 10.1038/372182a0

Kubota, 2000, Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia, Diabetes, 49, 1880, 10.2337/diabetes.49.11.1880

Terauchi, 2002, Impact of genetic background and ablation of IRS-3 on IRS-2 knockout mice, J Biol Chem

Ueki, 2002, Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase, Proc Natl Acad Sci U S A, 99, 419, 10.1073/pnas.012581799

Fruman, 2000, Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 alpha, Nat Genet, 26, 379, 10.1038/81715

Mauvais-Jarvis, 2002, Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance, Clin Endocrinol (Oxf), 57, 1, 10.1046/j.1365-2265.2002.01563.x

Cho, 2001, Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice, J Biol Chem, 276, 38349, 10.1074/jbc.C100462200

Stenbit, 1997, GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes, Nat Med, 3, 1096, 10.1038/nm1097-1096

Maier, 2000, Diabetes, 49, 618, 10.2337/diabetes.49.4.618

Hotamisligil, 1993, Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance, Science, 259, 87, 10.1126/science.7678183

Shoelson, 2003, Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance, Int J Obes Relat Metab Disord, 27, S49, 10.1038/sj.ijo.0802501

Yuan, 2001, Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta, Science, 293, 1673, 10.1126/science.1061620

Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J Clin Invest, 112, 1796, 10.1172/JCI200319246

Nguyen, 2007, A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways, J Biol Chem, 282, 35279, 10.1074/jbc.M706762200

Olefsky, 2010, Macrophages, inflammation, and insulin resistance, Annu Rev Physiol, 72, 219, 10.1146/annurev-physiol-021909-135846

Chen, 2005, Diet induction of monocyte chemoattractant protein-1 and its impact on obesity, Obes Res, 13, 1311, 10.1038/oby.2005.159

Weisberg, 2006, CCR2 modulates inflammatory and metabolic effects of high-fat feeding, J Clin Invest, 116, 115, 10.1172/JCI24335

Hotamisligil, 1995, Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance, J Clin Invest, 95, 2409, 10.1172/JCI117936

Hotamisligil, 1994, Tumor necrosis factor alpha: a key component of the obesity-diabetes link, Diabetes, 43, 1271, 10.2337/diabetes.43.11.1271

Hirosumi, 2002, A central role for JNK in obesity and insulin resistance, Nature, 420, 333, 10.1038/nature01137

Konner, 2010, Toll-like receptors: linking inflammation to metabolism, Trends Endocrinol Metab, 22, 16, 10.1016/j.tem.2010.08.007

Kumar, 2009, Toll-like receptors and innate immunity, Biochem Biophys Res Commun, 388, 621, 10.1016/j.bbrc.2009.08.062

Schaeffler, 2009, Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity, Immunology, 126, 233, 10.1111/j.1365-2567.2008.02892.x

Senn, 2006, Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes, J Biol Chem, 281, 26865, 10.1074/jbc.M513304200

Shi, 2006, TLR4 links innate immunity and fatty acid-induced insulin resistance, J Clin Invest, 116, 3015, 10.1172/JCI28898

Reyna, 2008, Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects, Diabetes, 57, 2595, 10.2337/db08-0038

Stein, 2004, The epidemic of obesity, J Clin Endocrinol Metab, 89, 2522, 10.1210/jc.2004-0288

Sanchez-Lasheras, 2010, Integrative neurobiology of energy homeostasis-neurocircuits, signals and mediators, Front Neuroendocrinol, 31, 4, 10.1016/j.yfrne.2009.08.002

Sandoval, 2008, The integrative role of CNS fuel-sensing mechanisms in energy balance and glucose regulation, Annu Rev Physiol, 70, 513, 10.1146/annurev.physiol.70.120806.095256

Escriva, 2007, Effect of age and moderate food restriction on insulin sensitivity in Wistar rats: role of adiposity, J Endocrinol, 194, 131, 10.1677/joe.1.07043

García-San Frutos, 2007, Impaired central insulin response in aged Wistar rats: role of adiposity, Endocrinology, 148, 5238, 10.1210/en.2007-0543

De Souza, 2005, Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus, Endocrinology, 146, 4192, 10.1210/en.2004-1520

Posey, 2009, Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet, Am J Physiol Endocrinol Metab, 296, E1003, 10.1152/ajpendo.90377.2008

Plum, 2006, Central insulin action in energy and glucose homeostasis, J Clin Invest, 116, 1761, 10.1172/JCI29063

Zhang, 2008, Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity, Cell, 135, 61, 10.1016/j.cell.2008.07.043

Ozcan, 2009, Endoplasmic reticulum stress plays a central role in development of leptin resistance, Cell Metab, 9, 35, 10.1016/j.cmet.2008.12.004

Nakatani, 2005, Involvement of endoplasmic reticulum stress in insulin resistance and diabetes, J Biol Chem, 280, 847, 10.1074/jbc.M411860200

Ozcan, 2004, Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes, Science, 306, 457, 10.1126/science.1103160

Lowell, 2005, Mitochondrial dysfunction and type 2 diabetes, Science, 307, 384, 10.1126/science.1104343

Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat Genet, 34, 267, 10.1038/ng1180

Petersen, 2003, Mitochondrial dysfunction in the elderly: possible role in insulin resistance, Science, 300, 1140, 10.1126/science.1082889

Lin, 2005, The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species, J Biol Chem, 280, 4617, 10.1074/jbc.M411863200

Evans, 2003, Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?, Diabetes, 52, 1, 10.2337/diabetes.52.1.1

Bloch-Damti, 2006, Differential effects of IRS1 phosphorylated on Ser307 or Ser632 in the induction of insulin resistance by oxidative stress, Diabetologia, 49, 2463, 10.1007/s00125-006-0349-6

Frank, 2005, The role of reactive oxygen species in insulin signaling in the vasculature, Antioxid Redox Signal, 7, 1053, 10.1089/ars.2005.7.1053

Kim, 2008, Role of mitochondrial dysfunction in insulin resistance, Circ Res, 102, 401, 10.1161/CIRCRESAHA.107.165472

Turner, 2008, Is mitochondrial dysfunction a cause of insulin resistance?, Trends Endocrinol Metab, 19, 324, 10.1016/j.tem.2008.08.001

Mogensen, 2007, Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes, Diabetes, 56, 1592, 10.2337/db06-0981

Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1, Proc Natl Acad Sci U S A, 100, 8466, 10.1073/pnas.1032913100

Ek, 2001, Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus, Diabetologia, 44, 2220, 10.1007/s001250100032

Hara, 2002, A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes, Diabetologia, 45, 740, 10.1007/s00125-002-0803-z

Meirhaeghe, 2003, Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo, Biochem J, 373, 155, 10.1042/bj20030200

Lelliott, 2006, Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance, PLoS Biol, 4, e369, 10.1371/journal.pbio.0040369

Nagai, 2009, The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance, Cell Metab, 9, 252, 10.1016/j.cmet.2009.01.011

Kopecky, 1996, Reduction of dietary obesity in aP2-Ucp transgenic mice: mechanism and adipose tissue morphology, Am J Physiol, 270, E776

Clapham, 2000, Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean, Nature, 406, 415, 10.1038/35019082

Unger, 2003, Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome, Endocrinology, 144, 5159, 10.1210/en.2003-0870

Unger, 2000, Lipotoxic diseases of nonadipose tissues in obesity, Int J Obes Relat Metab Disord, 24, S28, 10.1038/sj.ijo.0801498

Virtue, 2008, It's not how fat you are, it's what you do with it that counts, PLoS Biol, 6, e237, 10.1371/journal.pbio.0060237

Vidal-Puig, 2010, Special issue on lipotoxicity, Biochim Biophys Acta, 1801, 207, 10.1016/j.bbalip.2009.12.010

Moller, 2000, Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes, Trends Endocrinol Metab, 11, 212, 10.1016/S1043-2760(00)00272-1

Maeda, 2002, Diet-induced insulin resistance in mice lacking adiponectin/ACRP30, Nat Med, 8, 731, 10.1038/nm724

Knowler, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, 393, 10.1056/NEJMoa012512

Bruce, 2006, Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content, Am J Physiol Endocrinol Metab, 291, E99, 10.1152/ajpendo.00587.2005

Duncan, 2003, Exercise training, without weight loss, increases insulin sensitivity and postheparin plasma lipase activity in previously sedentary adults, Diabetes Care, 26, 557, 10.2337/diacare.26.3.557

Liu, 2007, Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance, J Clin Invest, 117, 1679, 10.1172/JCI30565

Yamaguchi, 2007, Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis, Hepatology, 45, 1366, 10.1002/hep.21655

Sewter, 2002, PPARgamma and the thiazolidinediones: molecular basis for a treatment of “Syndrome X”?, Diabetes Obes Metab, 4, 239, 10.1046/j.1463-1326.2002.00187.x

Koutnikova, 2003, Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice, Proc Natl Acad Sci U S A, 100, 14457, 10.1073/pnas.2336090100

He, 2003, Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle, Proc Natl Acad Sci U S A, 100, 15712, 10.1073/pnas.2536828100

Odegaard, 2007, Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance, Nature, 447, 1116, 10.1038/nature05894

Odegaard, 2008, Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance, Cell Metab, 7, 496, 10.1016/j.cmet.2008.04.003

Hevener, 2007, Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones, J Clin Invest, 117, 1658, 10.1172/JCI31561

Werman, 1997, Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin, J Biol Chem, 272, 20230, 10.1074/jbc.272.32.20230

Ren, 2002, PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis, Genes Dev, 16, 27, 10.1101/gad.953802

Vidal-Puig, 1997, Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids, J Clin Invest, 99, 2416, 10.1172/JCI119424

Medina-Gómez, 2005, The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform, Diabetes, 54, 1706, 10.2337/diabetes.54.6.1706

Zhang, 2004, Selective disruption of PPAR{gamma}2 impairs the development of adipose tissue and insulin sensitivity, Proc Natl Acad Sci U S A, 101, 10703, 10.1073/pnas.0403652101

Medina-Gómez, 2007, PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism, PLoS Genet, 3, e64, 10.1371/journal.pgen.0030064

Medina-Gómez, 2009, Adaptation and failure of pancreatic beta cells in murine models with different degrees of metabolic syndrome, Dis Model Mech, 2, 582, 10.1242/dmm.003251

Schipper, 2008, Regional anatomic and age effects on cell function of human adipose-derived stem cells, Ann Plast Surg, 60, 538, 10.1097/SAP.0b013e3181723bbe

Slawik, 2007, Adipose tissue expandability and the metabolic syndrome, Genes Nutr, 2, 41, 10.1007/s12263-007-0014-9

Tchkonia, 2007, Increased TNFalpha and CCAAT/enhancer-binding protein homologous protein with aging predispose preadipocytes to resist adipogenesis, Am J Physiol Endocrinol Metab, 293, E1810, 10.1152/ajpendo.00295.2007

Barroso, 1999, Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension, Nature, 402, 880, 10.1038/47254

Gray, 2006, Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice, Diabetes, 55, 2669, 10.2337/db06-0389

Marx, 1998, Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro, Am J Pathol, 153, 17, 10.1016/S0002-9440(10)65540-X

Ricote, 1998, Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein, Proc Natl Acad Sci U S A, 95, 7614, 10.1073/pnas.95.13.7614

Ricote, 1998, The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation, Nature, 391, 79, 10.1038/34178